Clinical Trial Update: Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients [Phase 3]

View source ↗

Summary

Phase 3 results update for an attachment inhibitor used in heavily treatment-experienced HIV-1 patients; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Rukobia (fostemsavir)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2018-09-18